BACKGROUND: Self-expanding metal stents (SEMS) are commonly used in the palliative treatment of malignant gastrointestinal (GI) obstructions with favorable short-term outcome. Data on long-term outcome are scarce, however. AIM: To evaluate long-term outcome after palliative stent treatment of malignant GI obstruction. METHOD: Between October 2006 and April 2008, nine Norwegian hospitals included patients treated with SEMS for malignant esophageal, gastroduodenal, biliary, and colonic obstructions. Patients were followed for at least 6 months with respect to stent patency, reinterventions, and readmissions. RESULTS: Stent placement was technically successful in 229 of 231 (99%) and clinically successful after 1 week in 220 of 229 (96%) patients. Long-term follow-up was available for 219 patients. Of those, 72 (33%) needed reinterventions. Stent occlusions or migrations (92%) were the most common reasons. Esophageal stents required reinterventions most frequently (41%), and had a significantly (p = 0.02) shorter patency (median 152 days) compared to other locations (gastroduodenal, 256 days; colon, 276 days; biliary, 460 days). Eighty percent of reinterventions were repeated endoscopic procedures that successfully restored patency. Readmissions were required for 156 (72%) patients. Progression of the underlying cancer was the most common reason, whereas 24% were readmitted due to stent complications. CONCLUSIONS: Long-term outcome after palliative treatment with SEMS for malignant GI and biliary obstruction shows that 70% had a patent stent until death, and that most reobstructions could be solved endoscopically. Hospital readmissions were mainly related to progression of the underlying cancer disease.
BACKGROUND: Self-expanding metal stents (SEMS) are commonly used in the palliative treatment of malignant gastrointestinal (GI) obstructions with favorable short-term outcome. Data on long-term outcome are scarce, however. AIM: To evaluate long-term outcome after palliative stent treatment of malignant GI obstruction. METHOD: Between October 2006 and April 2008, nine Norwegian hospitals included patients treated with SEMS for malignant esophageal, gastroduodenal, biliary, and colonic obstructions. Patients were followed for at least 6 months with respect to stent patency, reinterventions, and readmissions. RESULTS: Stent placement was technically successful in 229 of 231 (99%) and clinically successful after 1 week in 220 of 229 (96%) patients. Long-term follow-up was available for 219 patients. Of those, 72 (33%) needed reinterventions. Stent occlusions or migrations (92%) were the most common reasons. Esophageal stents required reinterventions most frequently (41%), and had a significantly (p = 0.02) shorter patency (median 152 days) compared to other locations (gastroduodenal, 256 days; colon, 276 days; biliary, 460 days). Eighty percent of reinterventions were repeated endoscopic procedures that successfully restored patency. Readmissions were required for 156 (72%) patients. Progression of the underlying cancer was the most common reason, whereas 24% were readmitted due to stent complications. CONCLUSIONS: Long-term outcome after palliative treatment with SEMS for malignant GI and biliary obstruction shows that 70% had a patent stent until death, and that most reobstructions could be solved endoscopically. Hospital readmissions were mainly related to progression of the underlying cancer disease.
Authors: Udayakumar Navaneethan; Sudhir Duvuru; Ramprasad Jegadeesan; Preethi G K Venkatesh; Norma G Gutierrez; Jeffrey Hammel; Ravi P Kiran; Madhusudhan R Sanaka Journal: Surg Endosc Date: 2014-04 Impact factor: 4.584
Authors: Joyce V Veld; Kim J Beek; Esther C J Consten; Frank Ter Borg; Henderik L van Westreenen; Wilhelmus A Bemelman; Jeanin E van Hooft; Pieter J Tanis Journal: Colorectal Dis Date: 2021-01-15 Impact factor: 3.788
Authors: Sung Ill Jang; Se Joon Lee; Seok Jeong; Don Haeng Lee; Myung-Hwan Kim; Hong Jin Yoon; Dong Ki Lee Journal: Gut Liver Date: 2017-07-15 Impact factor: 4.519
Authors: Anna Paeschke; Christian Bojarski; Susanne Küpferling; Thomas Hucklenbroich; Britta Siegmund; Severin Daum Journal: Case Rep Gastroenterol Date: 2016-05-26